
Medical Developments International Ltd
ASX:MVP

Intrinsic Value
The intrinsic value of one
MVP
stock under the Base Case scenario is
0.7
AUD.
Compared to the current market price of 0.64 AUD,
Medical Developments International Ltd
is
Undervalued by 9%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Medical Developments International Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Medical Developments International Ltd
Balance Sheet Decomposition
Medical Developments International Ltd
Current Assets | 33.4m |
Cash & Short-Term Investments | 17.6m |
Receivables | 7.8m |
Other Current Assets | 8m |
Non-Current Assets | 31.9m |
PP&E | 9.5m |
Intangibles | 22.4m |
Free Cash Flow Analysis
Medical Developments International Ltd
AUD | |
Free Cash Flow | AUD |
Earnings Waterfall
Medical Developments International Ltd
Revenue
|
38.1m
AUD
|
Cost of Revenue
|
-10m
AUD
|
Gross Profit
|
28.1m
AUD
|
Operating Expenses
|
-48.1m
AUD
|
Operating Income
|
-20.1m
AUD
|
Other Expenses
|
-9.7m
AUD
|
Net Income
|
-29.7m
AUD
|
MVP Profitability Score
Profitability Due Diligence
Medical Developments International Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Score
Medical Developments International Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
MVP Solvency Score
Solvency Due Diligence
Medical Developments International Ltd's solvency score is 84/100. The higher the solvency score, the more solvent the company is.

Score
Medical Developments International Ltd's solvency score is 84/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MVP Price Targets Summary
Medical Developments International Ltd
According to Wall Street analysts, the average 1-year price target for
MVP
is 0.72 AUD
with a low forecast of 0.72 AUD and a high forecast of 0.75 AUD.
Dividends
Current shareholder yield for MVP is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MVP
stock under the Base Case scenario is
0.7
AUD.
Compared to the current market price of 0.64 AUD,
Medical Developments International Ltd
is
Undervalued by 9%.